Asset Details
Do you wish to reserve the book?
Quality assurance during interstitial brachytherapy: in vivo dosimetry using MOSFET dosimeters
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Quality assurance during interstitial brachytherapy: in vivo dosimetry using MOSFET dosimeters
Do you wish to request the book?
Quality assurance during interstitial brachytherapy: in vivo dosimetry using MOSFET dosimeters
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Quality assurance during interstitial brachytherapy: in vivo dosimetry using MOSFET dosimeters
2018
Overview
Brachytherapy procedure may result in acute tissue reactions like edema, causing deviations between planned and measured doses. The rationale for
dosimetry in interstitial brachytherapy is to assess the accuracy of the delivered dose in comparison with the dose calculated by the treatment planning system (TPS).
One single computer tomography (CT) dataset was used for brachytherapy planning, taken within 24 hours after implantation.
interstitial measurements with micro-MOSFET-detectors (metal oxide semiconductor field effect transistor) were performed in 12 patients with different anatomic locations of cancers, including thorax-wall, head and neck, breast, and different types of implantations (monoplanar, loops, and multiplanar).
Measured values for the thorax-wall tumor patient showed a good agreement with the calculated data, with average deviation of -2.7% in 8 mm distance to the closest dwell position of the source. The deviation of the measured dose value of the head and neck patient was +55.6% in the first fraction and +8.5% in the last fraction. In the ten breast cancer patients, measured doses depended on the proximity of the detector to the irradiated volume PTV.
The deviations between planned and measured dose values were markedly influenced by the proximity of the detector to the PTV because where the edema exerts, the greatest influence on the tube applicator geometry. The positioning of the patient during irradiation must correspond to the positioning in the planning CT. Further studies are needed to investigate the role of
dosimetry during interstitial brachytherapy as a routine procedure.
